Product Application

NIMA-related kinase 7 (NEK7), once considered a "supporting actor" in cell cycle regulation, has now emerged as one of the most promising novel targets in the treatment of inflammatory diseases and tumors. As the critical "gatekeeper" for NLRP3 inflammasome assembly, targeted intervention of NEK7 offers a groundbreaking strategy for addressing a broad spectrum of diseases, ranging from myelodysplastic syndromes to neurodegenerative disorders.